Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Beximco Pharmaceuticals Limited BXP.L
$37.45
-$0.05 (-0.13%)
На 18:03, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
429891052.00000000
-
week52high
90.00
-
week52low
37.00
-
Revenue
34669172052
-
P/E TTM
503
-
Beta
0.74287600
-
EPS
0.08000000
-
Last Dividend
0.03000000
-
Next Earnings Date
07 мая 2023 г. в 06:00
Описание компании
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии